Viewing Study NCT06177132



Ignite Creation Date: 2024-05-06 @ 7:53 PM
Last Modification Date: 2024-10-26 @ 3:16 PM
Study NCT ID: NCT06177132
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-02-28
First Post: 2023-12-11

Brief Title: Vestibular Infant Screening - Rehabilitation
Sponsor: University Hospital Ghent
Organization: University Hospital Ghent

Study Overview

Official Title: Vestibular Infant Screening - Rehabilitation VIS-REHAB Protocol for a Randomised Controlled Trial on Vestibular Rehabilitation Therapy VRT in Vestibular-impaired Children
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VIS-REHAB
Brief Summary: The goal of this clinical trial is to investigate the short-term effect of a structured combined postural control and gaze stabilisation protocol VIS-REHAB protocol in a group of vestibular-impaired children of different age categories 3-17 years The main questions it aims to answer are

What is the short-term effect of the VIS-REHAB protocol
What are the most important factors that may influence the effect of and outcome after application of the VIS-REHAB protocol

The participant will undergo both an active rehabilitation program VIS-REHAB protocol and a period during which physical therapy is discontinued CTRL protocol

- VIS-REHAB protocol Postural control static and dynamic postural stability exercises gaze stability exercises oculomotor function and VOR-exercises general gross motor training with focus on gaze stability and postural control

Researchers will compare the VIS-REHAB protocol with receiving no therapy CTRL protocol to evaluate potential enhancements in postural stability gaze stability motor performance and quality of life
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None